doi: 10.1369/0022155410397999 167 KondoMSuzukiTKawanoYKojimaSMiyashiroMMatsumotoAet al
As more people begin taking GLP-1 receptor agonists and other incretin-based drugs for glycemic control and weight management, new side effects of these treatments (both good and bad) are emerging
As with other agents in the incretin-based injectable class, the most frequently reported side effects of retatrutide in clinical trials have been gastrointestinal in nature
These damages are typically reserved for cases where the defendant, in this case, Novo Nordisk, was grossly negligent or reckless in their actions
It was my first time going to Green Relief Health and it definitely won't be my last
They will consider factors like your current medications, kidney function, and history of certain medical conditions